翰思艾泰生物医药科技（武汉）股份有限公司（「翰思艾泰-B」，股票代码：03378）于2026年4月14日公告称，公司在香港联交所场内回购23,500股，占本次交易前已发行股份约0.017%。每股回购价介乎28.00港元至29.90港元，合计耗资约68.31万港元。回购后，公司已发行股份数为136,039,530股，库藏股数增加至179,300股。
公司于2026年2月12日通过相关股份购回授权，可回购总数为13,621,883股。截至本公告发布时，累计已回购179,300股，占授权当日已发行股份总数约0.1316%。公司确认本次股份购回严格遵守上市规则和相关法律规定。公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.